Senior Director, Marketing

Olema Oncology is  a clinical-stage biopharmaceutical company committed to transforming the standard of care and improving outcomes for patients living with  breast cancer  and beyond.   It’s  an exciting time to be part of Team Olema ,  with   our transfor mation into a fully   integrated oncology company well underway ,  t op-line data from our lead program expected  later  this  year ,   and our first potential commercial launch on the horizon. Our lead product candidate, palazestrant, is a novel, orally available complete estrogen receptor antagonist (CERAN) and selective estrogen receptor degrader (SERD) currently in two pivotal Phase 3 clinical trials. We expect top-line data from OPERA-01, our ongoing Phase 3 trial of palazestrant as a monotherapy in patients with second- or third-line ER+/HER2- metastatic breast cancer (MBC), in the fall which, if successful, could lead to our first potential approval and commercial launch in 2027. OPERA-02, our Phase 3 trial of palazestrant in combination with ribociblib in patients with frontline ER+/HER2- MBC, is enrolling patients. Together with its mechanism of action, pharmacokinetic properties, and the potential to demonstrate activity in both ESR1 wild-type and mutant tumors, palazestrant has the potential to transform the metastatic breast cancer treatment paradigm and access a $15 billion global market opportunity. Our follow-on product candidate, OP-3136, is a potent KAT6 inhibitor with the potential to generate further value and meaningfully impact the metastatic breast cancer treatment landscape – particularly in combination with palazestrant. We recently reported encouraging Phase 1 monotherapy data from this program across multiple solid tumor types and are advancing patient enrollment in the ongoing combination arms in MBC. Aspiring to transform the metastatic treatment paradigm is an ambitious endeavor that requires a resolute approach to developing better therapies and a passionate team dedicated to helping the patients we serve feel better, longer. We possess a deep commitment to our shared purpose, the sustained pursuit of excellence, cultivating the courage required to advance our programs, drive to succeed, and a collective capacity for adaptability through learning, growth, and evolution.  Team Olema is made up of nimble self-starters who bring consistency in their quest for the extraordinary every single day. If you’re ready to be part of a tenacious, courageous, agile, and growing team, join us in making a profound impact, together –  for  our patients, for your career,  and  for  what’s  beyond . About the Role >>> Senior Director, Marketing As the Senior Director, Marketing you will design and execute the Commercial roadmap that enables the successful potential U.S. launch of palazestrant, Olema’s lead program currently in Phase 3 for ER+ HER2- metastatic breast cancer. The ideal candidate will have experience in the commercialization of oral oncology therapies in breast cancer and a track record of leading successful oncology drug launches in the US. This role is based out of our San Francisco office and will require travel as needed. Your work will  primarily encompass: Building the strategic marketing plan and leading launch readiness initiatives (branding, positioning, messaging platform, story flow and creative imagery) to deliver a successful palazestrant launch Developing, prioritizing, and implementing market development activities that deepen awareness of unmet needs and address knowledge gaps among customers Designing the go-to-market approach that delivers resource-efficient customer engagement, customer behavior change and adoption at launch Developing KPIs to assess launch performance and analyzing market, customer, and competitor trends, incorporating insights into marketing strategies and plans Establishing a strong relationship with Medical Affairs, and eventually, the Sales team and other field-based commercial teams to ensure optimal execution Partnering cross-functionally with Clinical Development, Regulatory and other internal stakeholders to gather input for functional activities and ensure alignment with launch readiness activities Managing partner agency and vendor relationships and workflow Ensuring strategic and tactical plans meet compliance and regulatory guidelines and company policies Delivering marketing operating expenses within budget Ideal Candidate Profile  A love of challenging, important work. We are a pragmatic team, driven to imagine and develop meaningful therapies for improving lives. All employees within our company play a unique and crucial role in our success, both in accomplishing our mission and building a positive company culture. As such, we are looking for someone with the right combination of knowledge , experience , and attributes for this role. Knowledge: Bachelor’s degree required; MBA preferred Deep understanding of customer adoption behavior in breast cancer Knowledge of the laws and regulations regarding interactions with the healthcare community Experience: Minimum of 8 years of progressive commercial experience at biotechnology and/or pharmaceutical companies Successful history of developing and executing marketing strategy plans and leading the launch of new oncology products in the US Demonstrated ability to leverage insights and analytics to deliver impactful marketing strategies and tactics Ability to influence effectively across an organization at all levels Experience developing strategies to win in competitive markets Experience thriving in a small company environment, with a hands-on and pragmatic leadership style Excellent prioritization skills to deliver results within reasonably established timelines Attributes: Team player and collaborative: puts success of team above own interests; supports everyone's efforts to succeed; shares expertise with others Possesses a get-the-job do